Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescue

Abstract

Véronique Dartois and Thomas Dick discuss the evolution of drug discovery for the treatment of nontuberculous mycobacterial pulmonary disease (NTM-PD).